Uncategorized

Settembre 9, 2023

Role of MRI with diffusion-weighted imaging (DWI) in patients with uterine cervical cancer for intracavitary brachytherapy treatment alignment

Seventeen patients with locally advanced cancer (LACC) undergoing brachytherapy (BRT) after external beam radiotherapy (EBRT) were recruited. MR images were analysed, considering volume and ADC as variables during treatment. A significant decrease in volume during treatment was observed, more pronounced after EBRT than after BRT, which serves as a boost. Conversely, the ADC value appeared to increase somehow linearly with treatment, with mean initial values of 0.71 ± 0.06 × 10−3 mm2/s and final values of 1,29 ± 0.50 × 10−3 mm2/s. In relapsing patients, the difference between initial and post-treatment ADC values seemed significantly smaller compared to responder patients.
Settembre 9, 2023

Small renal masses management: a guidelines screenshot.

1. EAU Guidelines. Edn. presented at the EAU Annual Congress Milan 2023. ISBN 978-94-92671-19-6. 2. Escudier B, Porta C, Schmidinger M, Rioux-Leclercq N, Bex A, Khoo V, Grünwald V, Gillessen S, Horwich A; ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org. Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†. Ann Oncol. 2019 May 1;30(5):706-720. doi: 10.1093/annonc/mdz056. PMID: 30788497. 3. NCCN guidelines Kidney cancer, Version 4.2023. https://www.nccn.org/guidelines 4. Campell SC, Clark PE, Chang SS et al: Renal Mass and Localized Renal Cancer: Evaluation, Management, and Follow-Up: AUA Guideline Part I. J Urol 2021; 206: 199. 5. Campbell SC, Uzzo RG, Karam JA, et al: Renal Mass and Localized Renal Cancer: Evaluation, Management, and Follow-up: AUA Guideline: Part II. J Urol 2021; 206: 209. 6. Richard PO, Violette PD, Bhindi B, et al. Canadian Urological Association guideline:Management of small renal masses – Full-text. Can Urol Assoc J 2022;16(2):E61-75. http://dx.doi.org/10.5489/cuaj.7763
Settembre 2, 2023

Soothing the headache of pregnancy and post-partum neurological complications: A pictorial review

Neurological complications during pregnancy and the post-partum period pose a diagnostic challenge due to their often non-specific symptoms. Headaches, affecting up to 35% of pregnant women, can be the initial sign of a wide range of conditions, from benign migraines to rare life-threatening issues. Radiologists should be well versed on the key imaging features to guide prompt and appropriate management. While CT head is commonly the initial imaging choice due to availability, MRI offers greater sensitivity but comes with practical limitations and safety considerations, especially during pregnancy. Our comprehensive review illustrates the key imaging features of important neurological complications during this critical period, including cerebrovascular conditions (subarachnoid haemorrhage, venous sinus thrombosis, ischaemic stroke, eclamptic encephalopathy, PRES and RCVS), endocrine/metabolic disorders (Sheehan's syndrome and lymphocytic hypophysitis), and common primary CNS conditions that may manifest during pregnancy (neoplasms and multiple sclerosis).
Settembre 9, 2023

The added value of capsular enhancement sign (CES) in the extra-prostatic extension (EPE) grading system in predicting prostate cancer with extracapsular extension

MRI is fundamental in the diagnosis and staging of the prostate cancer. EPE score is a valid strategy to detect extra-capsular extension of the tumor. Our classification, combining EPE score together with “capsular enhancement sign” enhances the clinical accuracy in reporting the locoregional staging.
Settembre 9, 2023

The Adequacy of Ultrasound Guided Native Renal Biopsy

ESUR Scientific Poster
Settembre 7, 2023

The assessment of the Node Reporting and Data System (Node-RADS) in patients with cervical carcinoma

In 2018 FIGO revised the staging system of cervical carcinoma (cc) emphasizing the lymph node involvement (LNI), configured in stage IIIC. Recently Node-Rads has been introduced to provide a standardized assessment system for LNI based on 5 point scale. In our study, we have hypothesized that the Node-RADS score could accurately predict LNI in patients with cc, by correlating the results with histological data. The secondary objective focuses on assessing the applicability of the score among readers. From 2014 to 2023, 140 patients were taken care of our Department and underwent clinical examination, multiple biopsies, neoadjuvant chemotherapy and lymphadenectomy surgery. All patients performed MRI prior to treatment. Two readers, blinded to histopathological data, retrospectively classified lymph nodes (LN) according to the MRI node-RADS scoring system. The assigned scored was compared to the actual involvement of neoplasia on a statistical basis. Secondly three different readers have separately assigned a score for all LN detected by MRI. Overall data from 65 patients were collected. Retrospectively, the analysis was performed on the MRI images, by considering the main LN stations and dividing them into right and left station by assigning a NODE-RADS score for each. 397 lymph nodes were classified as NODE-RADS 1 , 42 as NODE-RADS 2, 34 as NODE RADS 3 , 25 as NODE-RADS 4 and 14 as NODE-RADS 5. By considering a Node-RADS 4–5 positive and a Node-RADS 1–2 negative, the PPV was 100% and the NPV was 80%. A crucial point was the NODE RADS 3 subgroup. Specifically of 34 LN classified as NODE-RADS 3,24 were subclassified as low risk and 10 were overclassified as high-risk, comparing with the anatomical-pathological data. Excellent inter-reader agreement was found. Our study demonstrates the prognostic potential of NODE-RADS MRI score for radiological standardization of LN in cc.
Settembre 9, 2023

THE NEW 2019 BOSNIAK CLASSIFICATION OF COMPLICATED RENAL CYSTS. RADIOPATHOLOGICAL CORRELATION AND CRITICAL REVIEW.

None
Settembre 9, 2023

The Prostate Imaging Quality Score (PI-QUAL): is inter-reader agreement a factor to consider?

The Prostate Imaging Quality Score (PI-QUAL): is inter-reader agreement a factor to consider? Introduction: In terms of diagnosis, Magnetic Resonance Imaging (MRI) stands out for its increasingly evident role in the detection and risk stratification of PCa. Optimal image acquisition is crucial to mantain high confidence on the technique and image quality check is currently considered mandatory. PI-QUAL has emerged as a tool for this but still lacks validation. Aims: The main purpose of this study is to assess the level of agreement between three raters with different levels of experience. Methods: We identified sixty-four patients with PCa in the same University Hospital in 2019. Therefore, three readers applied PI-QUAL Score independently. Results: We observed moderate interrater reliability between three readers of different experience assigning the PI-QUAL category to prostate MRI examinations and slight agreement for most qualitative/anatomical item. Conclusions: This scoring system can be used within commonly accepted levels of agreement, specially if a simplified 3-point scale version is used. However, it is anticipated that the scoring system will need to undergo further refinements. Keywords: Inter-Reader Agreement; Quality standards; Multiparametric Magnetic Resonance Imaging; Prostatic Cancer.
Settembre 9, 2023

The role of MRI in vulvar cancer staging according to the ESUR guidelines

Teaching Objectives. To review and illustrate the role of MRI in staging vulvar cancer based on the new European Society of Urogenital Radiology guidelines Review of the topic. Primary vulvar cancer is a rare tumor accounting for approximately 4% of all gynecologic malignancies. Squamous cell carcinoma (SCC) is the most usual type (>85% of all vulvar cancers). The most important prognostic factors include the size of the primary tumor and the regional lymph node status. Although imaging is not an integral part of the vulvar cancer FIGO staging, imaging performs an important role and MRI is the imaging modality of choice, according to the European Society of Urogenital Radiology(ESUR) vulvar cancer staging guidelines. Due to its superior tissue resolution, MRI is usually requested to better define the size of the tumor and its anatomic extension to the adjacent structures including the superficial (labia majora, minora, clitoris) and the deeper ones (urethra, vagina, and anus). According to the ESUR guidelines for primary tumors ≤2 cm, confined to the vulva or perineum, and with ≤1 mm of stromal invasion, imaging staging is not recommended. For local staging of SCC with stromal invasion >1 mm, tumor size >4 cm, or tumors with suspicious involvement of the urethra, vagina, or anus MRI should be performed. For tumors >2 cm and ≤4 cm, clinical staging and groin ultrasound or MRI staging are both considered valid options. For regional or locally advanced disease (FIGO stages III–IVA) or suspicious distant metastases (FIGO stage IVB),chest, abdominal and pelvic CT (or PET/CT) is recommended. Conclusion. MRI plays an important role in staging and treatment planning. Although MRI may be best suited for determining the extent of local disease and invasion, it is also helpful in identifying groin nodal metastases, which assist radiation planning.